Thomas Jahn

Head of Cardiopulmunary Disease

Thomas Jahn

“Folks, I don`t trust children. They`re here to replace us.”

—Stephen Colbert

PhD, Structural Biology, University of Leeds
Diploma, Biochemistry, University of Halle
Current Affiliation
Social Media

Thomas is Head of Cardiopulmonary Biology for Dewpoint Therapeutics. Most recently, Thomas was a Group Leader in the Neuroscience Discovery Organisation at AbbVie in Germany.

During his career in academia and pharmaceutical research, Thomas has founded a research laboratory at the German Cancer Research Center in Heidelberg focussing on generic concepts of protein misfolding disorders and has held a range of leadership roles for pre-clinical drug discovery projects. He has key expertise in establishing innovative disease models and translational strategies, and enjoys developing new therapeutic modalities for challenging drug discovery targets.

Thomas is a biochemist by training, holds a Ph.D. in structural biology from the University of Leeds, and has performed his postdoctoral work at the University of Cambridge.